Bandrone (50 mg (Tablets), 150 mg (Tablets), 06 mg (Vial))

NATCO PHARMA LIMITED (INDIA)

“Bandrone” contains Drug / Molecule called “Ibandronic acid”. It belongs to a class of medications known as bisphosphonate. The action of ibandronate on bone tissue is based partly on its affinity for hydroxyapatite, which is part of the mineral matrix of bone. It functions by preventing the breakdown of bone by bone cells known as osteoclasts. This activity inhibits osteoclast activity and reduces bone resorption and turnover.

Category:

Indication

Bandrone is used for the treatment and prevention of osteoporosis in postmenopausal women.

Note

Precaution

  • Bandrone is a prescription drug and should be used under proper medical guidance and advice.
  • Caution should be exercised in patients with history of allergy, taking any oral medications, undergoing radiation therapy, anemia, gastrointestinal problems including esophageal ulcer, cancer, infectious diseases, blood clotting problem, liver or kidney dis
  • Contraindicated during pregnancy and lactation

Related products